Ulcus cruris venosum (UCV) is the most severe form of chronic venous insufficiency and the quality of life of those affected is usually significantly impaired. In the updated s2k guideline published in 2024, the focus was on the prevention of UCV recurrences in addition to the quality of examination and treatment procedures. It is a practice-oriented guideline that combines the different approaches and levels of knowledge of the respective professional groups and offers a practicable treatment concept for UCV.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Tuberculosis
Detecting diabetes in TB patients early and efficiently
- Trichophyton indotineae
Terbinafine-resistant dermatophytoses are on the rise in Central Europe
- Peristomal skin health
Focus on preventive care options
- Disease-modifying therapies for ATTR-CM
TTR stabilizers, gene silencing and gene scissors: where do we stand?
- Proteins in wound healing
Do special amino acids lead to success?
- HER2+ early breast cancer
DESTINY-Breast11 – neoadjuvant T-DXd without anthracyclines
- Lavender aromatherapy
Take away the fear of the dentist
- Digital dermatology: innovative project examples